Literature DB >> 9542900

Molecular identification of Gemella species from three patients with endocarditis.

B La Scola1, D Raoult.   

Abstract

Gemella morbillorum and Gemella haemolysans are opportunistic pathogens which cause endocarditis and other severe infections. We report on three patients with endocarditis, one with endocarditis caused by G. haemolysans and two with endocarditis caused by G. morbillorum. The paucity of reports concerning these bacteria is probably related to the difficulties associated with their identification. For example, one of the strains reported in this study was originally sent to our laboratory with a preliminary characterization as a short "gram-negative" coccobacillus, highlighting the specific problem associated with Gram staining of these bacteria. The usefulness of 16S rRNA gene amplification, partial sequencing, and comparison of the nucleotide sequence to those in databases when standard phenotypic identification schemes are not helpful is emphasized. We also suggest that the use of simple tests, such as testing susceptibility to vancomycin for gram-negative bacteria and colistin for gram-positive bacteria, could prevent misinterpretation of Gram staining in gram-variable bacteria such as Gemella spp.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542900      PMCID: PMC104652          DOI: 10.1128/JCM.36.4.866-871.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Endocarditis due to Streptococcus morbillorum.

Authors:  S Maxwell
Journal:  J Infect       Date:  1989-01       Impact factor: 6.072

2.  Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods.

Authors:  A von Graevenitz; C Bucher
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

3.  Meningitis due to Gemella haemolysans after radiofrequency trigeminal rhizotomy.

Authors:  R G Mitchell; P J Teddy
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

4.  Endocarditis caused by Gemella haemolysans.

Authors:  A Kaufhold; D Franzen; R Lütticken
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

5.  Infective endocarditis due to Gemella morbillorum complicating hypertrophic obstructive cardiomyopathy.

Authors:  J R Kerr; C H Webb; J G McGimpsey; N P Campbell
Journal:  Ulster Med J       Date:  1994-04

6.  Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry.

Authors:  D T Durack; E L Kaplan; A L Bisno
Journal:  JAMA       Date:  1983-11-04       Impact factor: 56.272

7.  Endocarditis caused by Streptococcus morbillorum.

Authors:  H Coto; S L Berk
Journal:  Am J Med Sci       Date:  1984 May-Jun       Impact factor: 2.378

8.  Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococci.

Authors:  P C Appelbaum; M R Jacobs; J I Heald; W M Palko; A Duffett; R Crist; P A Naugle
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

10.  Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species.

Authors:  R R Facklam; D L Rhoden; P B Smith
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

View more
  25 in total

Review 1.  Current trends in the molecular diagnosis of infective endocarditis.

Authors:  B C Millar; J E Moore
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

2.  The influence of iron availability on human salivary microbial community composition.

Authors:  Renke Wang; Aida Kaplan; Lihong Guo; Wenyuan Shi; Xuedong Zhou; Renate Lux; Xuesong He
Journal:  Microb Ecol       Date:  2012-02-09       Impact factor: 4.552

3.  Gemella bacteraemia characterised by 16S ribosomal RNA gene sequencing.

Authors:  P C Y Woo; S K P Lau; A M Y Fung; S K Chiu; R W H Yung; K Y Yuen
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

4.  Gemella sanguinis: A rare cause of native valve endocarditis in a child.

Authors:  Mugunthan M; Sharad Bhalla; Vishal Shete; Naveen Grover
Journal:  Med J Armed Forces India       Date:  2015-12-31

5.  Use of groESL as a target for identification of Abiotrophia, Granulicatella, and Gemella species.

Authors:  Wei-Chun Hung; Sung-Pin Tseng; Hsiao-Jan Chen; Jui-Chang Tsai; Chih-Hsin Chang; Tai-Fen Lee; Po-Ren Hsueh; Lee-Jene Teng
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

6.  Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.

Authors:  Paula Cerdá Zolezzi; Leticia Millán Laplana; Carmen Rubio Calvo; Pilar Goñi Cepero; Melisa Canales Erazo; Rafael Gómez-Lus
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Gemella species endocarditis in a child.

Authors:  L K Purcell; J P Finley; R Chen; M Lovgren; S A Halperin
Journal:  Can J Infect Dis       Date:  2001-09

8.  Molecular epidemiology of macrolide and tetracycline resistances in commensal Gemella sp. isolates.

Authors:  Paula Cerdá Zolezzi; Pilar Goñi Cepero; Joaquim Ruiz; Leticia Millán Laplana; Carmen Rubio Calvo; Rafael Gómez-Lus
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

Review 9.  Mitral bioprosthetic valve endocarditis caused by an unusual microorganism, Gemella morbillorum, in an intravenous drug user.

Authors:  Ramzan M Zakir; Anthony Al-Dehneh; Leticia Dabu; Raj Kapila; Muhamed Saric
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Gemella bergeriae endocarditis diagnosed by sequencing of rRNA genes in heart valve tissue.

Authors:  Sameer Elsayed; Kunyan Zhang
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.